Bausch & Lomb (BLCO) Cash & Current Investments (2021 - 2026)
Bausch & Lomb (BLCO) posted Cash & Current Investments of $279.0 million for Q1 2026, down 29.72% on a QoQ basis from $397.0 million in Q4 2025, and up 29.77% year-over-year from $215.0 million in Q1 2025.
Bausch & Lomb (BLCO) Cash & Current Investments (2021 - 2026) Analysis & Trends
Bausch & Lomb's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $279.0 million for Q1 2026.
- Quarterly Cash & Current Investments rose 29.77% year-over-year to $279.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $279.0 million (up 29.77% YoY) and the FY2025 annual result came in at $397.0 million, up 25.63% from the prior year.
- Cash & Current Investments was $279.0 million for Q1 2026 at Bausch & Lomb, down from $397.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $446.0 million in Q2 2022 and bottomed at $190.0 million in Q1 2022.
- A 5-year average of $326.2 million and a median of $332.0 million in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments soared 114.69% — and 2025, when it plunged 33.85%.
- Bausch & Lomb's Cash & Current Investments stood at $380.0 million in 2022, then decreased by 12.11% to $334.0 million in 2023, then decreased by 5.39% to $316.0 million in 2024, then rose by 25.63% to $397.0 million in 2025, then decreased by 29.72% to $279.0 million in 2026.
- Business Quant data shows BLCO's Cash & Current Investments at $279.0 million in Q1 2026, $397.0 million in Q4 2025, and $332.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.79 Bn | 121.57 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 45.00 Bn | 44.18 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.50 Bn | 27.84 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.14 Bn | 22.71 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.88 Bn | 13.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.15 Bn | 11.09 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Bausch & Lomb | 5.85 Bn | 5.57 Bn | 973.00 Mn | 279.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 279.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Sep 30, 2025 | 332.00 Mn |
| Jun 30, 2025 | 272.00 Mn |
| Mar 31, 2025 | 215.00 Mn |
| Dec 31, 2024 | 316.00 Mn |
| Sep 30, 2024 | 350.00 Mn |
| Jun 30, 2024 | 302.00 Mn |
| Mar 31, 2024 | 325.00 Mn |
| Dec 31, 2023 | 334.00 Mn |
| Sep 30, 2023 | 360.00 Mn |
| Jun 30, 2023 | 392.00 Mn |
| Mar 31, 2023 | 358.00 Mn |
| Dec 31, 2022 | 380.00 Mn |
| Sep 30, 2022 | 297.00 Mn |
| Jun 30, 2022 | 446.00 Mn |
| Mar 31, 2022 | 190.00 Mn |
| Dec 31, 2021 | 177.00 Mn |